Pyroptosis‐Inducing Biomaterials Pave the Way for Transformative Antitumor Immunotherapy
Advanced Science · 2024-12 · 11 (47)
DOI: 10.1002/advs.202410336 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 06.11.2024. Verfasst von Hao Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Research, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, P. R. China. Hauptthemen laut MEDLINE: Biocompatible Materials, Immunotherapy, Neoplasms, Pyroptosis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Xijing Hospital medical staff training and promotion project-young doctor training program, Science and Technology Innovation Young Top Talents Programme of Wenzhou city.
Abstract (Originalsprache)
Pyroptosis can effectively overcome immunosuppression and reactivate antitumor immunity. However, pyroptosis initiation is challenging. First, the underlying biological mechanisms of pyroptosis are complex, and a variety of gasdermin family proteins can be targeted to induce pyroptosis. Second, other intracellular death pathways may also interfere with pyroptosis. The rationally designed gasdermin protein‐targeting biomaterials are capable of inducing pyroptosis and have the capacity to stimulate antitumor immune function in a safe and effective manner. This review provides a comprehensive overview of the design, function, and antitumor efficacy of pyroptosis‐inducing materials and the associated challenges, with a particular focus on the design options for pyroptosis‐inducing biomaterials based on the activation of different gasdermin proteins. This review offers a valuable foundation for the further development of pyroptosis‐inducing biomaterials for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Advanced Research, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, P. R. China.
- Department of Radiation and Medical Oncology, Wenzhou Key Laboratory of Basic Science and Translational Research of Radiation Oncology, Zhejiang Engineering Research Center for Innovation and Application of Intelligent…
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, P. R. China.
- Department of Oncology, Xijing Hospital of Air Force Military Medical University, Xi'an, Shaanxi, 710032, P. R. China.
- The First Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, 710061, P. R. China.
ORCID-Profile: Lei Li, Qinyang Wang
Förderung
- National Natural Science Foundation of China
- Xijing Hospital medical staff training and promotion project-young doctor training program
- Science and Technology Innovation Young Top Talents Programme of Wenzhou city
- Wenzhou Medical University
- Second Affiliated Hospital of Wenzhou Medical University
- Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Zitieren
APA
Yin, H., Chen, T., Hu, X., Zhu, W., Li, Y., Sun, W., Li, L., Zhang, H., & Wang, Q. (2024). Pyroptosis‐Inducing Biomaterials Pave the Way for Transformative Antitumor Immunotherapy. Advanced Science, 11(47). https://doi.org/10.1002/advs.202410336
Vancouver
Yin H, Chen T, Hu X, Zhu W, Li Y, Sun W, et al. Pyroptosis‐Inducing Biomaterials Pave the Way for Transformative Antitumor Immunotherapy. Advanced Science. 2024;11(47). doi:10.1002/advs.202410336
BibTeX
@article{Yin2024,
author = {Yin, Hao and Chen, Tanzhou and Hu, Xiaoqu and Zhu, Wenting and Li, Yida and Sun, Wenjie and Li, Lei and Zhang, Hongmei and Wang, Qinyang},
title = {Pyroptosis‐Inducing Biomaterials Pave the Way for Transformative Antitumor Immunotherapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {47},
doi = {10.1002/advs.202410336}
}
EUVIMED